This announcement is a separate document:
智飞生物：关于四价流感病毒裂解疫苗（ZFA02佐剂）获得临床试验批准通知书的公告
Zhifei Biotech: Announcement on the approval notice for the quadrivalent influenza virus lysis vaccine (ZFA02 adjuvant) for clinical trials
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.